Business Context and Reporting Period
This Form 10-QSB covers the quarterly period ended September 30, 2005, for Orthodontix, Inc. (Note: The request metadata listed "Protalix Biotherapeutics, Inc.", but the filing text explicitly identifies the issuer as Orthodontix, Inc.). The Company is a shell entity that terminated its affiliation with its founding orthodontic practices in 2001. It currently has no active operating business and is devoting its resources to identifying and consummating a merger or acquisition with an operating company.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2005 | Nine Months Ended Sep 30, 2005 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(31,946) | $(55,081) |
| Loss Per Share (Basic & Diluted) | $(0.01) | $(0.02) |
| General & Administrative Expenses | $35,885 | $67,194 |
| Interest & Other Income | $3,939 | $12,113 |
| Cash and Cash Equivalents (Sep 30, 2005) | $493,789 | |
| Total Liabilities (Sep 30, 2005) | $62,000 | |
| Accumulated Deficit (Sep 30, 2005) | $(3,792,834) | |
| Net Cash Used in Operating Activities (9 Months) | $(69,923) |
Material Changes Versus Prior Period
- Net Loss Reduction: The net loss for the nine months ended September 30, 2005, was approximately $55,000, a significant decrease from the $128,526 loss recorded in the same period in 2004.
- Expense Reduction: General and administrative expenses for the nine-month period dropped to $67,194 from $133,475 in the prior year period.
- Cash Flow Improvement: Net cash used in operating activities decreased to $69,923 for the nine months ended September 30, 2005, compared to $152,773 in the prior year.
- Investing Activities: Unlike the prior year, which saw $552,359 in cash provided by the redemption of investments, there were no investing activities in the current period.
Outlook, Risks, and Management Commentary
Plan of Operation: Management intends to continue seeking a business combination with an operating company in sectors such as aircraft maintenance, health care, pharmaceuticals, or financial services. The transaction would likely utilize common stock, cash on hand, or other funding sources.
Liquidity: The Company holds approximately $493,800 in cash and cash equivalents, primarily in money market accounts. Management believes these funds are sufficient to cover operating expenses for at least the next twelve months.
Risks and Contingencies:
- Going Concern: The financial statements are prepared assuming the Company will continue as a going concern, but this is contingent on the realization of assets and satisfaction of liabilities. The Company has an accumulated deficit of nearly $3.8 million.
- Acquisition Uncertainty: There are no assurances that the Company will successfully consummate a merger or acquisition, or that any such transaction will be profitable.
- Concentration Risk: As of June 30, 2005, the Company held $382,394 in bank deposits exceeding federally insured limits, though no losses have been experienced.
Key Facts for Investor Verification
- Verify the Company's current status as a shell entity with no operating revenue.
- Confirm the sufficiency of the $493,789 cash balance to sustain operations for the projected 12-month runway.
- Monitor progress on the search for a target acquisition, as the business model relies entirely on a future merger.
- Note the lack of stock options outstanding as of September 30, 2005.
- Review the accumulated deficit of $3,792,834 to understand the historical financial burden.